United States · Business magazines · Markets Insider (Business Insider)

Beeline Medicines Initiates First Trial in Lupus Pivotal Development Program with Global Phase 2/3 DISCOVERY Trial of Afimetoran in Cutaneous Lupus Erythematosus (CLE)

Published by Markets Insider (Business Insider) · United States 7 h ago

â Afimetoran, an investigational oral, once-daily, equipotent TLR7/8 inhibitor, targets a central driver of lupus biology with the potential to address both cutaneous and…

Read the full article on Markets Insider (Business Insider) Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (markets.businessinsider.com)

Also worth reading

Inc.

Martha Stewart Promoted Her QVC Line With a Homelessness Costume. Critics Called It ‘Ridiculously Offensive’

Quartz

10 highest mountains in the world, from Everest at 8,849 meters to Annapurna I

Fortune

The AI boom is facing another supply crunch. This time it’s the amount of capital available to feed Silicon Valley’s endless need for cash

Fast Company

Meta’s web crawlers are making life hell for owners of small business websites

Entrepreneur

Hackers Stole $6.3 Billion From Binance in the Biggest Crypto Heist Ever — Will Users Get Their Money Back?

Kiplinger